SalesTrax.com Research: XYZ company

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

PR Newswire

2009-08-24 16:00
FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria

2009-06-24 12:00
Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) Solution and Announcement of Lawsuit by Sepracor/UCB